Generic name | rotigotine | |
Strength | 2 mg/24h, 4 mg/24h, 6 mg/24h, 8 mg/24h | |
Form | transdermal patch |
Special Authority criteria | Approval period |
---|---|
For the treatment of advanced-stage Parkinson’s disease, when the patient is receiving treatment with levodopa and requires additional adjunctive therapy. |
Indefinite |